FORCE2018 has ended
FORCE2018 at McGill University on October 11-12, 2018 – with pre-conference workshops on Oct 10 hosted at Concordia University
Thursday, October 11 • 10:00am - 10:30am
Could Open Be the Yellow Brick Road to Innovation in Genomics in North America?

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Medical research in genomics advances at an accelerated pace. Every new discovery or invention creates a new and even more ambitious set of promises and associated expectations for improved healthcare. However, most of these promises are still to come to full fruition. Proponents of the patent system and its traditional proprietary model of commercialization claim that patents are the most effective instrument for providing the necessary incentives to allocate resources and efforts to advance innovation. However, the use of patents in genomics introduces major roadblocks leading to a slower, less efficient, and more burdensome innovation process. Moreover, patented innovation tends to be particularly costly contributing to the recent price rise of drugs, tests and medical devices. These high prices prevent poorer populations from obtaining the healthcare services they need. In order to create an improved innovation system in this field, a variety of open models of innovation have been proposed and used in addition to, or to replace, the patent system. In my presentation, I (and I call the audience to do it as well) consider whether open models of collaboration can pave a yellow brick road to future innovation. In order to do this, I present two projects in North America that have in fact adopted one or more open models of collaboration: Structural Genomics Consortium and Sage Bionetworks. I then open the discussion to determine to what extent can these models help advance innovation in genomics and where do they come short.

avatar for Palmira Granados Moreno

Palmira Granados Moreno

Academic Associate, McGill University